Critical Review: VanEck Biotech ETF (NASDAQ:BBH) vs. Invvlu Mu Incm (NYSE:IIM)

VanEck Biotech ETF (NASDAQ:BBH) and Invvlu Mu Incm (NYSE:IIM) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, earnings, risk and institutional ownership.

Profitability

This table compares VanEck Biotech ETF and Invvlu Mu Incm’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
VanEck Biotech ETF	N/A	N/A	N/A
Invvlu Mu Incm	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent ratings for VanEck Biotech ETF and Invvlu Mu Incm, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VanEck Biotech ETF	0	8	4	0	2.65
Invvlu Mu Incm	0	0	0	0	0.00

VanEck Biotech ETF presently has a consensus price target of $161.14, suggesting a potential upside of 0.00%. Given VanEck Biotech ETF’s stronger consensus rating and higher probable upside, equities research analysts clearly believe VanEck Biotech ETF is more favorable than Invvlu Mu Incm.

Risk and Volatility

VanEck Biotech ETF has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Invvlu Mu Incm has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500.

Earnings and Valuation

This table compares VanEck Biotech ETF and Invvlu Mu Incm”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VanEck Biotech ETF	N/A	N/A	N/A	N/A	N/A
Invvlu Mu Incm	N/A	N/A	N/A	N/A	N/A

Dividends

VanEck Biotech ETF pays an annual dividend of $1.25 per share and has a dividend yield of 0.8%. Invvlu Mu Incm pays an annual dividend of $0.54 per share and has a dividend yield of 4.6%.

Insider & Institutional Ownership

32.1% of VanEck Biotech ETF shares are held by institutional investors. Comparatively, 20.7% of Invvlu Mu Incm shares are held by institutional investors. 6.1% of Invvlu Mu Incm shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

VanEck Biotech ETF beats Invvlu Mu Incm on 4 of the 7 factors compared between the two stocks.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

About Invvlu Mu Incm

Invesco Value Municipal Income Trust is a closed-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., INVESCO Asset Management (Japan) Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, Invesco Canada Ltd., Invesco Hong Kong Limited, and INVESCO Senior Secured Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade municipal securities which include municipal bonds, municipal notes, municipal commercial paper, and lease obligations. It employs fundamental analysis with bottom-up security selection approach to create its portfolio. The fund was previously known as Invesco Insured Municipal Income Trust. Invesco Value Municipal Income Trust was formed on February 26, 1993 and is domiciled in the United States.